In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

Overview of attention for article published in Mayo Clinic Proceedings, July 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 32 news outlets
blogs: 9 blogs
policy: 3 policy sources
twitter: 150 X users
peer_reviews: 1 peer review site

facebook: 18 Facebook pages
googleplus: 2 Google+ users
reddit: 1 Redditor
bluesky: 1 Bluesky user

Readers on

mendeley: 119 Mendeley

So far, Altmetric has seen 13 posts from 9 blogs.

Bad Medicine, Part 2: (Drug) Trials and Tribulations (Rebroadcast)

Freakonomics, 24 Aug 2017

Birth defects resulting from thalidomide led medical researchers to exclude women of child-bearing age from clinical trials. (Pho…

Bad Medicine, Part 1: The Story of 98.6 (Rebroadcast)

Freakonomics, 17 Aug 2017

We think modern medicine is pretty advanced, but what if we’re wrong about something as simple as the average body temperature? …

Drug Pricing Reform Even Big Pharma Might Like

Science and Enterprise, 02 May 2016

(TBIT/Pixabay) 2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of…

Drug Pricing Debate Once Again Ignited

Penn Medicine News Blog, 06 Oct 2015

A few weeks ago, news broke that the founder of Turing Pharmaceuticals, Martin Shkreli, bought the 62-year-old drug daraprim…

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity, including 9 additional blog posts.